DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD*2A, c.2846A>T, c.1679T>G and c.1236G>A

Additional Metadata
Persistent URL	doi.org/10.1093/annonc/mdy281, hdl.handle.net/1765/125542
Journal	Annals of Oncology
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Henricks, L.M. (L. M.), Lunenburg, C.A.T.C. (C. A.T.C.), de Man, F., Meulendijks, D., Frederix, G., Kienhuis, E., … Schellens, J. (2018). DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A. Annals of Oncology*, 29. doi:10.1093/annonc/mdy281

Publication